Pfizer buys Seagen for US$43B, boosts access to cancer drugs

France Nouvelles Nouvelles

Pfizer buys Seagen for US$43B, boosts access to cancer drugs
France Dernières Nouvelles,France Actualités
  • 📰 CTVCalgary
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 68%

Pfizer is spending about US$43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.

The pharmaceutical giant said Monday it will pay US$229 in cash for each share of Seagen Inc. Pfizer then plans to let the biotech drug developer "continue innovating," except with more resources than it would have alone, Pfizer Chairman and CEO Albert Bourla told analysts.

Cancer treatments are a priority for Pfizer. They brought in US$12 billion in revenue for the drugmaker last year. But Pfizer has only marketed a couple first-generation ADC treatments, a spokeswoman said. Seagen's top seller, Adcetris, treats lymph system cancers. It brought in US$839 million in sales last year, a 19% increase over the previous year.

Bourla said earlier this year that the company planned to use its "extraordinary firepower" to buy products that will deliver US$25 billion in incremental revenue by 2030.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

CTVCalgary /  🏆 26. in CA

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Pfizer buys Seagen for $43B, boosts access to cancer drugsPfizer buys Seagen for $43B, boosts access to cancer drugsPfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.
Lire la suite »

Pfizer buys Seagen for $43-billion, boosts access to cancer drugsPfizer buys Seagen for $43-billion, boosts access to cancer drugsThe deal will combine Seagen’s technology with Pfizer’s scale and strength, Pfizer CEO Albert Bourla says in a statement
Lire la suite »

Pfizer buys Seagen for $43 Billion, boosts access to cancer drugsPfizer buys Seagen for $43 Billion, boosts access to cancer drugsPfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.
Lire la suite »

N.S. government will spend $1.62 billion on capital projects in the 2023-24 fiscal year | SaltWireN.S. government will spend $1.62 billion on capital projects in the 2023-24 fiscal year | SaltWireHALIFAX, N.S. — The Nova Scotia government plans to invest a record $1.62 billion in capital spending for the 2023-24 fiscal year, focusing on health-care ...
Lire la suite »

Nova Scotia government says it will spend $1.6-billion on infrastructure in coming yearNova Scotia government says it will spend $1.6-billion on infrastructure in coming yearFinance Minister Allan MacMaster said the province’s planned 2023-24 spending on highways, schools, hospitals and land reflects the needs of Nova Scotia’s growing population
Lire la suite »

Hollywood stars spend Oscars eve at annual Chanel dinnerHollywood stars spend Oscars eve at annual Chanel dinner$openGraphObjectMap.get($ogKey)
Lire la suite »



Render Time: 2025-03-27 21:59:37